OpenLegislation

Annex

United Kingdom

Original text. Later amendments are not shown.

  1. A..

    Annex II is modified as follows:

    1. 1..

      Inorganic chemicals

      Pharmacologically active substances(s)Animal speciesOther provisions
      ‘Potassium nitrateAll food producing species
      Potassium DL-aspartateAll food producing species
      Potassium glucuronateAll food producing species
      Potassium glycerophosphateAll food producing species’
  2. B..

    Annex III is modified as follows:

    1. 1..

      Anti-infectious agents

      1. 1.2.

        Antibiotics

        1. 1.2.11.

          Florfenicol and related compounds

          Pharmacologically active substanceMarker residueAnimal speciesMRLsTarget tissuesOther provisions
          ‘FlorfenicolSum of florfenicol and its metabolites measured as florfenicol-amineFish1 000 µg/kgMuscle and skin in natural proportionsProvisional MRLs expire on 1.7.2001’
    2. 2..

      Antiparasitic agents

      1. 2.1.

        Agents acting against endoparasites

        1. 2.1.1.

          Benzimidazoles and pro-benzimidazoles

          Pharmacologically active substanceMarker residueAnimal speciesMRLsTarget tissuesOther provisions
          ‘Albendazole sulphoxideSum of albendazole, albendazole sulphoxide, albendazole sulphone and albendazole 2-amino sulphone, expressed as albendazoleBovine, ovine, pheasant1 000 µg/kgLiverProvisional MRLs expire on 1.1.2000’
          500 µg/kgKidney
          100 µg/kgMuscle, fat
          Bovine, ovine100 µg/kgMilk
      1. 2.3.

        Agents acting against endo- and ectoparasites

        1. 2.3.1.

          Avermectins

          Pharmacologically active substanceMarker residueAnimal speciesMRLsTarget tissuesOther provisions
          ‘MoxidectinMoxidectinEquidae50 µg/kgMuscleProvisional MRLs expire on 1.1.2000’
          500 µg/kgFat
          100 µg/kgLiver
          50 µg/kgkidney
    3. 4..

      Anti-inflammatory agents

      1. 4.1.

        Nonsteroidal anti-inflammatory agents

        1. 4.1.1.

          Arylpropionic acid derivative

          Pharmacologically active substanceMarker residueAnimal speciesMRLsTarget tissuesOther provisions
          ‘CarprofenCarprofenBovine1 000 µg/kgLiver, kidneyProvisional MRLs expire on 1.1.2000’
          500 µg/kgMuscle, fat
          Equidae1 000 µg/kgLiver, kidney
          50 µg/kgMuscle
          100 µg/kgFat
  3. C..

    Annex IV is modified as follows:

    List of pharmacologically active substances for which no maximum levels can be fixed

    ‘Metronidazole.’